Financials
Income statement
| Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|
| Total reported revenue | — | 7.3B | 6.6B | 6.6B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | 2.4B | 2.3B | 2.2B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | — | 2.8B | 2.4B | 2.4B |
| Tax provision | 591M | 659M | 525M | 644M |
| Net income | — | 2.2B | 1.9B | 1.8B |
| Basic EPS | — | 2.2 | — | 1.8 |
| Diluted EPS | — | 2.2 | — | 1.8 |
| Basic average shares | 938.5M | 942.0M | — | 943.5M |
| Diluted average shares | — | 947.3M | — | 945.8M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | 2.2B | 1.9B | 1.8B |
| Minority interests | — | -8M | -8M | -9M |
| Preferred stock dividends | — | — | — | — |